164 related articles for article (PubMed ID: 15596777)
1. Rituximab stabilizes multifocal motor neuropathy increasingly less responsive to IVIg.
Rüegg SJ; Fuhr P; Steck AJ
Neurology; 2004 Dec; 63(11):2178-9. PubMed ID: 15596777
[TBL] [Abstract][Full Text] [Related]
2. Beneficial effect of rituximab monotherapy in multifocal motor neuropathy.
Stieglbauer K; Topakian R; Hinterberger G; Aichner FT
Neuromuscul Disord; 2009 Jul; 19(7):473-5. PubMed ID: 19467601
[TBL] [Abstract][Full Text] [Related]
3. An open-label trial of rituximab (Rituxan®) in multifocal motor neuropathy.
Chaudhry V; Cornblath DR
J Peripher Nerv Syst; 2010 Sep; 15(3):196-201. PubMed ID: 21040141
[TBL] [Abstract][Full Text] [Related]
4. Worsening after rituximab treatment in anti-mag neuropathy.
Broglio L; Lauria G
Muscle Nerve; 2005 Sep; 32(3):378-9. PubMed ID: 15986418
[No Abstract] [Full Text] [Related]
5. An open label clinical trial of complement inhibition in multifocal motor neuropathy.
Fitzpatrick AM; Mann CA; Barry S; Brennan K; Overell JR; Willison HJ
J Peripher Nerv Syst; 2011 Jun; 16(2):84-91. PubMed ID: 21692905
[TBL] [Abstract][Full Text] [Related]
6. Prolonged neutropenia following anti CD20 therapy in a patient with relapsed follicular non-Hodgkin's lymphoma and corrected with IVIG.
Saikia TK; Menon H; Advani SH
Ann Oncol; 2001 Oct; 12(10):1493-4. PubMed ID: 11762825
[No Abstract] [Full Text] [Related]
7. A smooth transition protocol for patients with multifocal motor neuropathy going from intravenous to subcutaneous immunoglobulin therapy: an open-label proof-of-concept study.
Misbah SA; Baumann A; Fazio R; Dacci P; Schmidt DS; Burton J; Sturzenegger M
J Peripher Nerv Syst; 2011 Jun; 16(2):92-7. PubMed ID: 21692906
[TBL] [Abstract][Full Text] [Related]
8. Nerve excitability changes after intravenous immunoglobulin infusions in multifocal motor neuropathy and chronic inflammatory demyelinating neuropathy.
Boërio D; Créange A; Hogrel JY; Guéguen A; Bertrand D; Lefaucheur JP
J Neurol Sci; 2010 May; 292(1-2):63-71. PubMed ID: 20219211
[TBL] [Abstract][Full Text] [Related]
9. Immunoglobulins in chronic inflammatory demyelinating polyneuropathy.
Comi G; Quattrini A; Fazio R; Roveri L
Neurol Sci; 2003 Oct; 24 Suppl 4():S246-50. PubMed ID: 14598053
[TBL] [Abstract][Full Text] [Related]
10. Chronic neuropathy with IgM anti-ganglioside antibodies: lack of long term response to rituximab.
Rojas-García R; Gallardo E; de Andrés I; de Luna N; Juarez C; Sánchez P; Illa I
Neurology; 2003 Dec; 61(12):1814-6. PubMed ID: 14694058
[TBL] [Abstract][Full Text] [Related]
11. [Improvement of severe and intravenous immunoglobulin-dependent multifocal motor neuropathy with conduction block after long-term rituximab].
Michaud A; Delmont E; Jeandel PY; Desnuelle C
Rev Neurol (Paris); 2011 Dec; 167(12):916-20. PubMed ID: 21752414
[TBL] [Abstract][Full Text] [Related]
12. New liquid intravenous immunoglobulin (10 % IVIg) for treatment of multifocal motor neuropathy: a prospective study of efficacy, safety and tolerability.
Cats EA; van der Pol WL; Piepers S; Notermans NC; van den Berg-Vos RM; van den Berg LH
J Neurol; 2008 Oct; 255(10):1598-9. PubMed ID: 18758888
[No Abstract] [Full Text] [Related]
13. Treatment of immune-mediated, dysimmune neuropathies.
Finsterer J
Acta Neurol Scand; 2005 Aug; 112(2):115-25. PubMed ID: 16008538
[TBL] [Abstract][Full Text] [Related]
14. Rituximab treatment in patients with IVIg-dependent immune polyneuropathy: a prospective pilot trial.
Gorson KC; Natarajan N; Ropper AH; Weinstein R
Muscle Nerve; 2007 Jan; 35(1):66-9. PubMed ID: 16967492
[TBL] [Abstract][Full Text] [Related]
15. [Intravenous IgG for treatment of neuromuscular diseases].
Vedeler CA; Mellgren SI; Omdal R; Torbergsen T; Aasly J
Tidsskr Nor Laegeforen; 2010 Sep; 130(17):1717-20. PubMed ID: 20835282
[TBL] [Abstract][Full Text] [Related]
16. [Immunoglobulin therapy of chronic inflammatory neuropathies].
Grehl H; Jaspert A; Claus D; Neundörfer B
Nervenarzt; 1996 Dec; 67(12):1003-10. PubMed ID: 9082188
[TBL] [Abstract][Full Text] [Related]
17. Chronic ataxic neuropathy with cold agglutinins: atypical phenotype and response to anti-CD20 antibodies.
Siddiqui K; Cahalane E; Keogan M; Hardiman O
Neurology; 2003 Nov; 61(9):1307-8. PubMed ID: 14610153
[No Abstract] [Full Text] [Related]
18. Childhood-Onset Multifocal Motor Neuropathy with IgM Antibodies to Gangliosides GM1: A Case Report with Poor Outcome.
Pro S; Ursitti F; Pruneddu GL; Di Capua M; Valeriani M
Neuropediatrics; 2021 Oct; 52(5):406-409. PubMed ID: 33511596
[TBL] [Abstract][Full Text] [Related]
19. Intravenous immunoglobulin infusion in multifocal demyelinating motor neuropathy: a case report.
Lin YY; Tsai CP; Ting YC; Lin KP; Liao KK; Kao KP; Wang SJ
Zhonghua Yi Xue Za Zhi (Taipei); 1995 Jul; 56(1):66-9. PubMed ID: 7553414
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of intravenous immunoglobulin in multifocal motor neuropathy.
Vlam L; Cats EA; Willemse E; Franssen H; Medic J; Piepers S; Veldink JH; van den Berg LH; van der Pol WL
J Neurol Neurosurg Psychiatry; 2014 Oct; 85(10):1145-8. PubMed ID: 24336791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
